Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001728117-25-000029
Filing Date
2025-04-29
Accepted
2025-04-29 16:01:26
Documents
21
Period of Report
2025-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A goss-20250429.htm   iXBRL DEF 14A 879005
6 GRAPHIC goss-20250429_g1.jpg GRAPHIC 150783
7 GRAPHIC goss-20250429_g2.jpg GRAPHIC 263246
8 GRAPHIC goss-20250429_g3.jpg GRAPHIC 272291
9 GRAPHIC goss-20250429_g4.jpg GRAPHIC 148326
10 GRAPHIC goss-20250429_g5.jpg GRAPHIC 84420
  Complete submission text file 0001728117-25-000029.txt   3851486

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT goss-20250429.xsd EX-101.SCH 5334
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT goss-20250429_def.xml EX-101.DEF 3172
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT goss-20250429_lab.xml EX-101.LAB 10873
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT goss-20250429_pre.xml EX-101.PRE 7256
23 EXTRACTED XBRL INSTANCE DOCUMENT goss-20250429_htm.xml XML 139261
Mailing Address 3115 MERRYFIELD ROW SUITE 120 SAN DIEGO CA 92121
Business Address 3115 MERRYFIELD ROW SUITE 120 SAN DIEGO CA 92121 (858) 684-1300
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

EIN.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38796 | Film No.: 25886974
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)